Fabrizio Stocchi Selected Research

Fabrizio Stocchi Research Topics

Disease

110	Parkinson Disease (Parkinson's Disease) 12/2024 - 09/2002
32	Dyskinesias (Dyskinesia) 05/2024 - 09/2002
8	Dementia (Dementias) 12/2023 - 01/2019
6	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2020
6	Fatigue 02/2022 - 05/2011
5	Disease Progression 04/2024 - 01/2003
4	Tremor (Tremors) 04/2024 - 11/2012
4	Cognitive Dysfunction 10/2023 - 06/2012
4	Constipation 01/2023 - 12/2015
4	Deglutition Disorders (Dysphagia) 01/2023 - 12/2009
4	Pain (Aches) 02/2022 - 01/2017
3	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2020 - 11/2013
2	REM Sleep Behavior Disorder 04/2024 - 09/2020
2	Injection Site Reaction 03/2024 - 11/2021
2	Psychotic Disorders (Schizoaffective Disorder) 10/2023 - 09/2020
2	Nausea 10/2023 - 01/2016
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 11/2012
2	Parkinsonian Disorders (Parkinsonism) 06/2015 - 12/2009
2	Hallucinations (Hallucination) 11/2013 - 03/2003
1	Chronic Renal Insufficiency 10/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2023
1	Neurobehavioral Manifestations 09/2023
1	Anhedonia 09/2023
1	Dysbiosis 01/2023
1	Infections 01/2023
1	Movement Disorders (Movement Disorder) 02/2022
1	Tauopathies 01/2022
1	Headache (Headaches) 01/2022
1	Seizures (Absence Seizure) 01/2021
1	Heart Failure 09/2020
1	Disorders of Excessive Somnolence (Hypersomnia) 09/2020
1	Orthostatic Hypotension (Postural Hypotension) 09/2020
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 09/2020
1	Nocturia 03/2020
1	Inflammation (Inflammations) 01/2020
1	Back Pain (Backache) 01/2020
1	Prodromal Symptoms 01/2019

Drug/Important Bio-Agent (IBA)

61	Levodopa (L Dopa)FDA LinkGeneric 12/2024 - 09/2002
14	Carbidopa (Lodosyn)FDA LinkGeneric 03/2024 - 06/2005
12	Dopamine Agonists (Dopamine Agonist)IBA 01/2023 - 07/2003
8	Apomorphine FDA Link 11/2023 - 05/2003
6	opicaponeIBA 11/2022 - 07/2017
6	levodopa methyl esterIBA 12/2019 - 01/2007
6	rasagiline (Azilect)FDA Link 10/2016 - 11/2008
5	safinamideIBA 02/2022 - 01/2012
5	Dopamine Receptors (Dopamine Receptor)IBA 05/2011 - 07/2006
4	SynucleinsIBA 04/2024 - 01/2017
4	Antidepressive Agents (Antidepressants)IBA 12/2023 - 01/2017
4	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 10/2023 - 09/2010
4	Dopamine (Intropin)FDA LinkGeneric 09/2020 - 07/2010
4	ropinirole (Requip)FDA LinkGeneric 06/2011 - 07/2003
3	Monoclonal AntibodiesIBA 04/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
3	TabletsIBA 01/2015 - 07/2010
3	entacapone (Comtan)FDA Link 07/2013 - 04/2009
3	Dopamine Agents (Dopaminergic Agents)IBA 05/2011 - 07/2006
2	catechol (pyrocatechol)IBA 10/2023 - 10/2018
2	TransferasesIBA 10/2023 - 10/2018
2	BenserazideIBA 10/2023 - 03/2020
2	mesoglycanIBA 03/2022 - 11/2021
2	istradefyllineIBA 01/2021 - 11/2018
2	Carboxy-LyasesIBA 01/2021 - 12/2018
2	EnzymesIBA 11/2020 - 12/2009
2	Antipsychotic Agents (Antipsychotics)IBA 11/2020 - 12/2009
2	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 06/2017 - 12/2015
2	Adenosine (Adenocard)FDA LinkGeneric 06/2017 - 12/2015
2	mavoglurantIBA 01/2016 - 11/2013
2	Cabergoline FDA LinkGeneric 06/2015 - 07/2003
2	sirioIBA 01/2015 - 07/2010
2	ProdrugsIBA 07/2010 - 01/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2005 - 03/2003
1	Monoamine Oxidase (MAO)IBA 04/2024
1	SolutionsIBA 03/2024
1	Nerve Growth Factors (Neurotrophins)IBA 12/2023
1	Apolipoproteins AIBA 01/2023
1	Aromatic Amino Acid Decarboxylase InhibitorsIBA 01/2023
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 11/2022
1	Glutamic Acid (Glutamate)FDA Link 02/2022
1	Hyaluronic Acid (Hyaluronan)IBA 02/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 11/2020
1	CytochromesIBA 09/2020
1	hydroxide ionIBA 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	amsonic acid (DAS)IBA 05/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019

Therapy/Procedure

35	Therapeutics 05/2024 - 09/2002
5	Activities of Daily Living (ADL) 01/2020 - 03/2010
3	Electrodes (Electrode) 01/2023 - 12/2022
2	Deep Brain Stimulation 11/2023 - 07/2006
1	Subcutaneous Infusions 03/2024
1	Renal Dialysis (Hemodialysis) 10/2023
1	Intravenous Infusions 01/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 09/2020
1	Duration of Therapy 12/2019
1	Oral Administration 01/2019